TCT 2013: Higher pacemaker rate marks difference between Medtronic's, Edwards Lifesciences' TAVI devices

October 28, 2013 by Arezu Sarvestani

A retrospective analysis reports near-identical outcomes for transcatheter aortic valve implantation systems by medtech rivals Medtronic and Edwards Lifesciences, but Edwards' Sapien tallies a win for its corner with fewer patients requiring permanent pacemakers following TAVI.

TCT 2013: Researchers find few differences between CoreValve and Sapien outcomes

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp